← Open Payments lookup

HEIDI ROMERO: Open Payments

NPI 1306607908 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,446 in 117 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,978 · 2025 $2,446

Food & beverage: $2,446
CompanyPaymentsAmount
Alkermes, Inc.20$358
Vanda Pharmaceuticals Inc.10$350
Otsuka America Pharmaceutical, Inc.15$314
ABBVIE INC.25$231
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$196
E.R. Squibb & Sons, L.L.C.5$162
Axsome Therapeutics, Inc.5$139
Teva Pharmaceuticals USA, Inc.1$123
Biogen, Inc.1$105
Takeda Pharmaceuticals U.S.A., Inc.4$93

Products named: FANAPT, ARISTADA, REXULTI, VRAYLAR, CAPLYTA, COBENFY, Auvelity, UZEDY.

Industry payments across LA — which companies pay providers there.